Ketogenic and carnivore diets for Crohn's disease, ulcerative colitis and rheumatoid arthritis
Tests two diets on symptoms and quality of life in adults with these conditions.
Key facts
- Who runs it
- Fuller Research Foundation
- Where
- Charlottesville, United StatesSee the site
- Trial code
- Registry title
- Ketogenic and Carnivore (Lion) Diets for Inflammatory Bowel Disease and Rheumatoid Arthritis
- Status
- Recruiting
- People taking part
- 160 people, planned
- Started
- 17 Feb 2026
- Expected to end
- Sept 2027
- Type of study
- Interventional, 7 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Ketogenic diet
- Carnivore (Lion) Diet
- Record updated
- 5 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with inflammatory bowel disease (ulcerative colitis or Crohn's disease) or rheumatoid arthritis who can follow a ketogenic or carnivore diet.
- Age
- 18 to 64 years
- Sex
- All sexes can join.
- Disease stage
- A medically verifiable diagnosis of inflammatory bowel disease or rheumatoid arthritis, with symptoms.
- Earlier treatment
- People who started a disease-modifying or biologic medication in the past 2 months cannot join. People with a blood transfusion in the past 6 months cannot join.
Main reasons for not taking part
- Pregnancy, 6 months postpartum or breastfeeding
- Type 1 or Type 2 diabetes treated with prescription medicines, including insulin
- History of strictures or fistula (IBD)
- Organ failure, including heart, liver or kidney failure or disease
- History of cancer within the last year
The registry criteria, word for word
Show all 19 criteriaShow less
Who can take part
- Diagnosed with medically verifiable IBD or medically verifiable RA
- Current personal residence in the continental U.S
- Willingness and ability to follow dietary protocols
Who cannot take part
- History of blood transfusion in the previous 6 months
- On other medications outside of FDA approved medications
- Unable to complete, for any reason, the initial 3-week run-in period prior to the beginning of the formal study intervention
- Individuals with Type 1 or Type II Diabetes on prescription medications including insulin
- History of strictures or fistula (IBD)
- Current initiation of disease modifying or biologic medication within the past 2 months
- Organ failure of any kind including heart, liver and kidney failure or disease
- History of malignancy within the last year prior to enrollment
- Red meat allergy, alpha-gal allergy
- Outside of the age or BMI criteria
- Inability to provide consent
- No medically definitive or verifiable diagnosis of IBD or RA
- Pregnancy
- 6 months Postpartum
- Breastfeeding
- Non-English Speaking
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 64 years old?
Where in United States
- Resilient Roots: Functional MedicineCharlottesville, United StatesContact: Robert D Abbott, MDTaking people
About the trial
What the trial wants to find out
This study is a randomized controlled clinical trial evaluating whether two therapeutic dietary approaches - a ketogenic diet and a carnivore (lion) diet - can improve quality of life, reduce symptoms, and influence measures of disease activity in adults with inflammatory bowel disease [ulcerative colitis and Crohn's disease] (IBD) or rheumatoid arthritis (RA).
Read full original descriptionShow less
Participants will be randomized into one of three groups: 1) Ketogenic Diet, 2) Carnivore (Lion) Diet or 3) Wait-List Control.
Participants randomized to a dietary group (ketogenic diet or carnivore diet) will be provided guidance on their specific dietary therapy and answer questions about their symptoms and quality of life at different intervals over a 24 week period. Participants will also complete laboratory testing at different intervals to assess for changes in nutritional status, cardiometabolic health and markers of immune activation and inflammation.
Participants initially placed on the wait-list group will be asked similar questions about their symptoms and quality of life and complete the same laboratory testing as participants in a dietary group. Participants on the wait list will then be compared to participants following a specific dietary pattern to assess for any differences between the 2 groups. After 12 weeks, participants on the wait list will be randomized to a dietary group (ketogenic diet or carnivore diet) and followed in a similar fashion for an additional 12 week period.
The 7 groups in the trial
- Ketogenic Diet 24 WeeksTreatment being tested
Participants with IBD or RA randomized initially to receive dietary counseling regarding the ketogenic diet for up to 24 weeks
Treatment: Ketogenic diet
- Carnivore (Lion) Diet 24 WeeksTreatment being tested
Participants with IBD or RA randomized initially to receive dietary counseling regarding the carnivore (lion) diet for up to 24 weeks
Treatment: Carnivore (Lion) Diet
- Wait List 12 WeeksNo study treatment, for comparison
Participants with IBD or RA randomized initially to a 12 week waitlist who will continue their baseline dietary pattern WITHOUT specific dietary guidance/intervention
- Carnivore (Lion) Diet for 12 weeks AFTER Wait-ListTreatment being tested
Participants with IBD or RA randomized initially to the wait-list for 12 weeks who are then randomized to receive dietary counseling regarding the carnivore (lion) diet for a subsequent 12 weeks
Treatment: Carnivore (Lion) Diet
- Ketogenic Diet for 12 Weeks AFTER Wait-ListTreatment being tested
Participants with IBD or RA randomized initially to the wait-list for 12 weeks who are then randomized to receive dietary counseling regarding the carnivore (lion) diet for a subsequent 12 weeks
Treatment: Ketogenic diet
- Voluntary Crossover - Ketogenic Diet to Carnivore (Lion) Diet AFTER 12 weeksTreatment being tested
Participants with IBD or RA randomized initially to the ketogenic diet for 12 weeks who voluntarily choose to crossover to the carnivore (lion) diet intervention for the final 12 weeks
Treatment: Ketogenic diet and Carnivore (Lion) Diet
- Voluntary Crossover - Carnivore (Lion) Diet to Ketogenic Diet AFTER 12 weeksTreatment being tested
Participants with IBD or RA randomized initially to the carnivore (lion) diet for 12 weeks who voluntarily choose to crossover to the ketogenic diet intervention for the final 12 weeks
Treatment: Ketogenic diet and Carnivore (Lion) Diet
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Effectiveness and Efficacy of a Ketogenic or Carnivore (Lion) Diet for Quality Life and Symptom Burden in Individuals With Symptomatic Inflammatory Bowel Disease or Rheumatoid Arthritis: A Randomized Controlled Clinical Trial
- Plain-language title
- Ketogenic and carnivore diets for Crohn's disease, ulcerative colitis and rheumatoid arthritisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT07524244, who can take part
- Record updated
- 5 October 2026